Stockreport

Novo Nordisk (NVO) Reports 10% Sales Growth as Obesity Care Hits DKK 82B [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk (NYSE: NVO ) is one of the stocks that should double in 3 years . On February 4, Novo Nordisk delivered 10% sales growth in 2025, driven by its obesity and [Read more]